MTARC1 and steatosis: Likely due to changes in hepatocyte secretion of VLDLs. mARC1 knockdown in vitro in human hepatocytes reduces lipid accumulation; hepatocyte-specific knockdown in vivo in mice reduces steatosis/steatohepatitis42